ACADIA Pharmaceuticals
ACAD
#3659
Rank
S$3.90 B
Marketcap
$23.49
Share price
0.40%
Change (1 day)
-39.28%
Change (1 year)

Earnings for ACADIA Pharmaceuticals (ACAD)

Earnings in 2024 (TTM): S$0.18 Billion

According to ACADIA Pharmaceuticals's latest financial reports the company's current earnings are S$0.92 Billion. In 2023 the company made an earning of -S$68.87 Million, an increase over its 2022 earnings that were of -S$0.29 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for ACADIA Pharmaceuticals from 2003 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) S$0.18 B-362.68%
2023 -S$68.87 Million-76.09%
2022 -S$0.29 Billion27.41%
2021 -S$0.23 Billion-40.38%
2020 -S$0.38 Billion19.88%
2019 -S$0.32 Billion-3.92%
2018 -S$0.33 Billion-15.04%
2017 -S$0.39 Billion6.33%
2016 -S$0.37 Billion64.55%
2015 -S$0.23 Billion77.47%
2014 -S$0.13 Billion143.69%
2013 -S$51.21 Million81.93%
2012 -S$28.15 Million-8.73%
2011 -S$30.84 Million-251.39%
2010 S$20.36 M-133.2%
2009 -S$61.36 Million-30.82%
2008 -S$88.69 Million6.43%
2007 -S$83.34 Million25.89%
2006 -S$66.2 Million36.99%
2005 -S$48.32 Million37.22%
2004 -S$35.22 Million19.96%
2003 -S$29.36 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$50.57 Million-127.42%๐Ÿ‡บ๐Ÿ‡ธ USA
S$9.36 B 4,979.27%๐Ÿ‡บ๐Ÿ‡ธ USA
S$13.69 B 7,325.76%๐Ÿ‡บ๐Ÿ‡ธ USA
S$24.82 B 13,357.16%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$9.29 Billion-5,133.18%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$52.13 Million-128.26%๐Ÿ‡บ๐Ÿ‡ธ USA